Sirius Medical

Sirius Medical is a pioneering company specializing in Health Care and Medical Devices. Founded in 2017 and headquartered in The Netherlands, the company aims to enhance the care provided to cancer patients through the delivery of exceptional and cost-effective solutions that facilitate the precise and efficient removal of tumors.

The company emerged as a spin-off from the Netherlands Cancer Institute, where researchers identified the necessity to streamline and enhance localization technology for the surgical extraction of breast cancers. This initiative materialized in the development and clinical demonstration of the pioneering magnetic seed localization, subsequently evolved and perfected into the Sirius Pintuition System.

Representing the next generation of tumor localization technology, Sirius Pintuition introduces the concept of Surgical Marker Navigation, offering a wire-free localization technology with intuitive guidance facilitated by the state-of-the-art GPSDetect™ software and unique TargetLOC™ feature. This real-time directional guidance system ensures superior precision in locating tumors, enhancing the efficiency and accuracy of the process.

The company's CE-marked and FDA-cleared system, available in over 200 centers in the United States and western Europe, provides a simple, precise, and accurate platform, ultimately delivering an improved experience for both patients and physicians.

Having received a significant €10.00M Venture Round investment at 04 February 2025, Sirius Medical has attracted funding from a consortium of investors including Curie Capital, Invest-NL, Holland Capital, NextGen Ventures, De Groot Family Office, BOM, and Team Holmium.

In summary, Sirius Medical is revolutionizing the field of tumor localization with its innovative Surgical Marker Navigation technology, poised to have a substantial impact on cancer care and treatment processes.